Comment from Department of Psychiatry Yale School of Medicine

Summary: Researchers from the Yale School of Medicine argue that the FDA should prioritize evidence of complete smoking abstinence rather than mere reduction when evaluating flavored e-cigarettes. They also express concern that many non-tobacco flavors appeal to youth and may pose toxicological risks, recommending stricter scrutiny of these products.